resiquimod has been researched along with Actinic Keratosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Farr, MA; Joshi, TP; Lewis, DJ | 1 |
| Anliker, M; Brüning, H; Dummer, R; French, LE; Hengge, UR; Hofbauer, GFL; Hunger, T; Kenzelmann, R; Popp, G; Reinhold, U; Stockfleth, E; Surber, C; Szeimies, RM; Ulrich, C | 1 |
| Rajaratnam, R | 1 |
1 trial(s) available for resiquimod and Actinic Keratosis
| Article | Year |
|---|---|
Topical resiquimod dosing regimens in patients with multiple actinic keratoses: a multicentre, partly placebo-controlled, double-blind clinical trial.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imidazoles; Keratosis, Actinic; Male; Middle Aged; Placebos; Time Factors; Toll-Like Receptor 7; Toll-Like Receptor 8; Treatment Outcome | 2019 |
2 other study(ies) available for resiquimod and Actinic Keratosis
| Article | Year |
|---|---|
Resiquimod: a new topical immune-response modifier for the treatment of actinic keratosis.
Topics: Adjuvants, Immunologic; Humans; Imidazoles; Imiquimod; Keratosis, Actinic | 2021 |
Resiquimod for actinic keratosis: is this a new treatment option?
Topics: Double-Blind Method; Humans; Imidazoles; Keratosis, Actinic | 2019 |